Pharmacoepidemiology and Drug Safety

Papers
(The H4-Index of Pharmacoepidemiology and Drug Safety is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
90
Comparative Effectiveness of Atezolizumab, Nivolumab and Pembrolizumab in Second‐Line Treatment of Advanced Non–Small Cell Lung Cancer73
Advancing Health Equity in Europe: Explore, Tailor, Implement, and Evaluate (ETIE)—A Framework of Diversity and Fairness in Pharmacoepidemiologic Research59
Validation of diagnosis codes for chorioamnionitis in medical encounter data, 2013–201850
Dipeptidyl Peptidase 4 Inhibitors: Novel Therapeutic Agents in the Management of Type II Diabetes Mellitus46
Issue Information45
Quantitative Benefit–Risk Assessment of Vaccination Against COVID‐19: A Systematic Review43
Validation of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Coding in US Claims Data42
Antibiotics and Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: Analysis of Brazilian Pharmacovigilance Registries42
Correction to “Effect of tramadol and DOACs with special attention to dabigatran on concomitant use, on the risk of mayor bleeding using 41
Data Resource Profile: The Danish National Hospital Medicine Register35
Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study33
Letter to the Editor32
Causal Forests Versus Inverse Probability of Treatment Weighting to Adjust for Cluster‐Level Confounding: A Parametric and Plasmode Simulation Study Based on US 31
External validity in distributed data networks27
All Lines Is the Right Approach: Selecting Patient Lines of Therapy for an External Comparator Arm27
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark27
ORAL PRESENTATION25
Warfarin‐Associated Bleeding and Thromboembolic Events in Sub‐Saharan Africa: A Systematic Review and Meta‐Analysis24
Development and Validation of an Endometrial Cancer Algorithm in US Claims Data22
Issue Information22
Mixed Impact of Direct Healthcare Professional Communications When Considering Proximal Outcomes and the Targeted Population: A Systematic Review21
Optimizing therapeutic decision‐making for off‐label medicines use: A scoping review and consensus recommendations for improving practice and research+21
0.17600297927856